Rituximab+ Zanubrutinib for Patients With Hairy Cell Leukemia and Hairy Cell Variant
1d agoen
From the article
Conditions : Hairy Cell Leukemia; Hairy Cell Leukemia Variant Interventions : Drug: Zanubrutinib Sponsors : Bnai Zion Medical Center; Meir Medical Center; Hadassah Medical Organization Enrolling by invitation
Continue reading on clinicaltrials.govYou might also wanna read
Real-World EV Plus Pembro Success Seen in Urothelial Cancer
Medscape·20h ago
Antibody-Drug Conjugates in Perioperative Treatment of Muscle-Invasive Bladder Cancer: Expert Perspectives
This article discusses the emerging role of antibody-drug conjugates (ADCs) in the perioperative treatment of muscle-invasive bladder cancer
mdsc.pe·8d agoGlaxoSmithKline and Genmab submit Arzerra (Ofatumumab) application to FDA for the treatment of advanced stage blood cancer
GSK·17y ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.